Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 07 Jan 2025

Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response

in Cancer Immunity and Immunotherapy

Weisen Ning
Sheng Yan
Yongyao Song
Hanning Xu
Jinling Zhang
Xiaomei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504124

704 views

Original Research

Published on 06 Jan 2025

Chemokine family significance and prognostic value in colorectal cancer

in Cancer Immunity and Immunotherapy

Yi Ding
Yinnan Chen
Siyun Xie
Quanpeng Qiu
Xiaolong Guo
Yun Feng
Hongxia Li
Fang Zhu
Yaping Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404768

646 views

Original Research

Published on 06 Jan 2025

SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells

in Cancer Immunity and Immunotherapy

Melissa Bernhardt
Anne Rech
Marion Berthold
Melina Lappe
Jan-Niklas Herbel
Florian Erhard
Annette Paschen
Bastian Schilling
Andreas Schlosser

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490821

1,001 views

Original Research

Published on 06 Jan 2025

The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer

in Cancer Immunity and Immunotherapy

Rachel Pounds
Wayne Croft
Hayden Pearce
Tasnia Hossain
Kavita Singh
Janos Balega
David N. Jeevan
Sudha Sundar
Sean Kehoe
Jason Yap

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477781

841 views

Original Research

Published on 06 Jan 2025

The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis

in Cancer Immunity and Immunotherapy

Beibei Wu
Ding Luo
Xuejie Wang
Chen Qiao
Rui Li
Jian Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1511866

1,099 views

Original Research

Published on 06 Jan 2025

Integrating bioinformatics and machine learning to identify AhR-related gene signatures for prognosis and tumor microenvironment modulation in melanoma

in Cancer Immunity and Immunotherapy

Qianru Li
Heli Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1519345

944 views

Original Research

Published on 06 Jan 2025

Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation

in Cancer Immunity and Immunotherapy

Oana Hangiu
Rocío Navarro
Susana Frago
Laura Rubio-Pérez
Antonio Tapia-Galisteo
Laura Díez-Alonso
Marina Gómez-Rosel
Noelia Silva-Pilipich
Lucía Vanrell
Cristian Smerdou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494206

2,297 views

Review

Published on 06 Jan 2025

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors

in Cancer Immunity and Immunotherapy

Safwaan H. Khan
Yeonjoo Choi
Mysore Veena
John K. Lee
Daniel Sanghoon Shin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489827

3,604 views

Case Report

Published on 06 Jan 2025

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series

in Cancer Immunity and Immunotherapy

Lingyu Tan
Guozhen Yang
Chufeng Zeng
Xu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1502206

648 views

Original Research

Published on 06 Jan 2025

Single-cell sequencing analysis reveals cancer-associated pericyte subgroup in esophageal squamous cell carcinoma to predict prognosis

in Cancer Immunity and Immunotherapy

Kai Xiong
Bing Pan
Hao Fang
Ziyou Tao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474673

931 views

Original Research

Published on 03 Jan 2025

Identification of MYC and STAT3 for early diagnosis based on the long noncoding RNA-mRNA network and bioinformatics in colorectal cancer

in Cancer Immunity and Immunotherapy

Kunhou Yao
Hao Fan
Tiancheng Yang
Can Yang
Guibin Wang
Xingwang Li
Xin-Ying Ji
Qun Wang
Shaojiang Lv
Shihao Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497919

871 views

Original Research

Published on 03 Jan 2025

Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas

in Cancer Immunity and Immunotherapy

Hui Tang
Xuping Yang
Guoqian Li
Ke Peng
Yang Sun
Longyang Jiang
Yilan Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488894

628 views

Original Research

Published on 03 Jan 2025

A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection

in Cancer Immunity and Immunotherapy

Ping Li
Ziyi Jiang
Jingjing Shi
Haochuan Sha
Zihang Yu
Yan Zhao
Sanyang Han
Lan Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1530364

1,051 views

Editorial

Published on 03 Jan 2025

Editorial: Novel reliable approaches for prediction and clinical decision-making in cancer

in Cancer Immunity and Immunotherapy

Ines Zidi
Safa Bhar Layeb
Vera Rebmann

Frontiers in Immunology

doi 10.3389/fimmu.2024.1537956

505 views

Original Research

Published on 03 Jan 2025

β-receptor blocker enhances anti-tumor immunity via inhibiting lactate-induced norepinephrine metabolism of macrophages during malignant pleural effusion

in Cancer Immunity and Immunotherapy

Ru Zhang
Weijia Wang
Aitian Li
Huishang Wang
Xiaoyan Liu
Feifei Fan
Ying Wang
Huanyu Zhang
Jingxia Chang
Yinyin Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497468

751 views

Mini Review

Published on 02 Jan 2025

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Yidan Shan
Di He
Fengguo Yan
Weijia Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522820

649 views

Navigation group

Articles

Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response

Chemokine family significance and prognostic value in colorectal cancer

SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells

The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer

The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis

Integrating bioinformatics and machine learning to identify AhR-related gene signatures for prognosis and tumor microenvironment modulation in melanoma

Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series

Single-cell sequencing analysis reveals cancer-associated pericyte subgroup in esophageal squamous cell carcinoma to predict prognosis

Identification of MYC and STAT3 for early diagnosis based on the long noncoding RNA-mRNA network and bioinformatics in colorectal cancer

Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas

A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection

Editorial: Novel reliable approaches for prediction and clinical decision-making in cancer

β-receptor blocker enhances anti-tumor immunity via inhibiting lactate-induced norepinephrine metabolism of macrophages during malignant pleural effusion

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma